Obstetrics & Gynecology · Montgomery, AL
NPI
1346566700
Since 2010
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1758 Park Pl, Suite 406
Montgomery, AL, 36106
Phone (251) 716-4744
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,698
179 services
Medicare patients, 2024
85
Average age 66
Drug cost, 2024
$120K
1,417 prescriptions
Company payments, 2025
$524
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Latoya S Clark was code G0101 (cervical or vaginal cancer screening; pelvic and clinical breast examination), 40 times for 40 patients. In total Latoya S Clark billed 179 services in 33 codes, and Medicare paid $7,698.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-26.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Facility | 40 | 40 | $24.40 | $976 |
| 99212 Office E&M - Established | Facility | 27 | 25 | $24.72 | $668 |
| 99213 Office E&M - Established | Facility | 22 | 18 | $39.27 | $864 |
| Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Facility | 19 | 19 | $16.67 | $317 |
By year: 2022 $15K for 311 services; 2023 $10K for 200 services; 2024 $7,698 for 179 services.
Medicare prescription drug claims, 2024
In 2024, the drug Latoya S Clark prescribed most often to Medicare patients was Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl), with 232 prescriptions and refills. In total Latoya S Clark wrote 1,417 Medicare prescriptions that cost $120K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 232 | 237 | 47 | $30K |
| Estradiol Generic | 125 | 283 | 47 | $5,626 |
| Fluconazole Generic | 125 | 125 | 74 | $978 |
| Metronidazole Generic | 83 | 84 | 62 | $643 |
| Valacyclovir Valacyclovir Hcl | 73 | 93 | 26 | $2,389 |
| Buprenorphine Hcl Generic | 69 | 69 | 19 | $1,487 |
| Nystatin Generic | 46 | 46 | 27 | $530 |
| Ibuprofen Generic | 38 | 38 | 31 | $143 |
| Gabapentin Generic | 33 | 34 | Under 11 | $318 |
| Clonazepam Generic | 30 | 30 | Under 11 | $109 |
| Ciprofloxacin Hcl Generic | 30 | 30 | 27 | $117 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 29 | 77 | 13 | $733 |
| Sprintec Norgestimate-Ethinyl Estradiol | 25 | 41 | Under 11 | $355 |
| Suboxone Buprenorphine Hcl/Naloxone Hcl | 24 | 24 | Under 11 | $16K |
| Hydroxyzine Pamoate Generic | 23 | 23 | Under 11 | $97.06 |
Brand drugs: - claims; generic drugs: 1,298 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Latoya S Clark $524 ($524 in general payments such as food, travel and fees) from 11 companies. The largest payer was Becton, Dickinson and Company with $110.
| Company | Payments | Amount |
|---|---|---|
| Becton, Dickinson and Company BDX | 3 | $110 |
| Sumitomo Pharma America, Inc. 4506.T | 6 | $92.85 |
| Astellas Pharma US Inc 4503.T | 4 | $87.31 |
| Shield Therapeutics Inc STX.L | 3 | $65.18 |
| Organon LLC OGN | 2 | $46.92 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $23.1 |
| Hologic Sales and Service, LLC HOLX | 1 | $22.68 |
| Novo Nordisk Inc NVO | 1 | $22.32 |
| Millicent US Inc | 1 | $20.1 |
| Lilly USA, LLC LLY | 1 | $16.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.